These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

801 related articles for article (PubMed ID: 17549249)

  • 1. Adoptive T cell therapy for cancer in the clinic.
    June CH
    J Clin Invest; 2007 Jun; 117(6):1466-76. PubMed ID: 17549249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T-cell adoptive immunotherapy using tumor-infiltrating T cells and genetically engineered TCR-T cells.
    Ikeda H
    Int Immunol; 2016 Jul; 28(7):349-53. PubMed ID: 27127191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T-cell-based Immunotherapy: Adoptive Cell Transfer and Checkpoint Inhibition.
    Houot R; Schultz LM; Marabelle A; Kohrt H
    Cancer Immunol Res; 2015 Oct; 3(10):1115-22. PubMed ID: 26438444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. One size does not fit all: personalized immune therapies poised to take center stage.
    Azvolinsky A
    J Natl Cancer Inst; 2013 May; 105(9):583-4. PubMed ID: 23591459
    [No Abstract]   [Full Text] [Related]  

  • 5. Principles of adoptive T cell therapy in cancer.
    Met Ö; Jensen KM; Chamberlain CA; Donia M; Svane IM
    Semin Immunopathol; 2019 Jan; 41(1):49-58. PubMed ID: 30187086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Update on Adoptive T-Cell Therapy and Neoantigen Vaccines.
    Ott PA; Dotti G; Yee C; Goff SL
    Am Soc Clin Oncol Educ Book; 2019 Jan; 39():e70-e78. PubMed ID: 31099621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer immunotherapy: a treatment for the masses.
    Blattman JN; Greenberg PD
    Science; 2004 Jul; 305(5681):200-5. PubMed ID: 15247469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adoptive Cellular Therapy (ACT) for Cancer Treatment.
    Yang F; Jin H; Wang J; Sun Q; Yan C; Wei F; Ren X
    Adv Exp Med Biol; 2016; 909():169-239. PubMed ID: 27240459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of adoptive cell therapy for cancer: a clinical perspective.
    Hawkins RE; Gilham DE; Debets R; Eshhar Z; Taylor N; Abken H; Schumacher TN; ATTACK Consortium
    Hum Gene Ther; 2010 Jun; 21(6):665-72. PubMed ID: 20408760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetically engineered T cells as adoptive immunotherapy of cancer.
    Ma Q; Gonzalo-Daganzo RM; Junghans RP
    Cancer Chemother Biol Response Modif; 2002; 20():315-41. PubMed ID: 12703212
    [No Abstract]   [Full Text] [Related]  

  • 11. Current developments of immunotherapy in the clinic.
    Antonia S; Mulé JJ; Weber JS
    Curr Opin Immunol; 2004 Apr; 16(2):130-6. PubMed ID: 15023403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adoptive cellular immunotherapy of cancer.
    Winter H; Fox BA
    Curr Opin Mol Ther; 1999 Feb; 1(1):89-97. PubMed ID: 11249690
    [No Abstract]   [Full Text] [Related]  

  • 13. T cell immunotherapy.
    McKee MD; Fichera A; Nishimura MI
    Front Biosci; 2007 Jan; 12():919-32. PubMed ID: 17127349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strategies to genetically engineer T cells for cancer immunotherapy.
    Spear TT; Nagato K; Nishimura MI
    Cancer Immunol Immunother; 2016 Jun; 65(6):631-49. PubMed ID: 27138532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The cutting edge of antitumor adoptive cell therapy].
    Nakatsugawa M; Yamashita Y; Hirano N
    Rinsho Ketsueki; 2011 Oct; 52(10):1713-20. PubMed ID: 21971251
    [No Abstract]   [Full Text] [Related]  

  • 16. Engineered cells for costimulatory enhancement combined with IL-21 enhance the generation of PD-1-disrupted CTLs for adoptive immunotherapy.
    Shao J; Xu Q; Su S; Meng F; Zou Z; Chen F; Du J; Qian X; Liu B
    Cell Immunol; 2017 Oct; 320():38-45. PubMed ID: 28935250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T cell engineering as therapy for cancer and HIV: our synthetic future.
    June CH; Levine BL
    Philos Trans R Soc Lond B Biol Sci; 2015 Oct; 370(1680):20140374. PubMed ID: 26416683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T lymphocyte therapy of cancer.
    Michálek J; Büchler T; Hájek R
    Physiol Res; 2004; 53(5):463-9. PubMed ID: 15479123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Principles of adoptive T cell cancer therapy.
    June CH
    J Clin Invest; 2007 May; 117(5):1204-12. PubMed ID: 17476350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reprogramming the tumor microenvironment to enhance adoptive cellular therapy.
    Beavis PA; Slaney CY; Kershaw MH; Gyorki D; Neeson PJ; Darcy PK
    Semin Immunol; 2016 Feb; 28(1):64-72. PubMed ID: 26611350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.